| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/04/2012 | CN101654453B Process for the manufacture of the calcium salt of rosuvatatin and crystalline intermediates thereof |
| 07/04/2012 | CN101647875B Plant extract for treating bradycardia |
| 07/04/2012 | CN101607913B 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/04/2012 | CN101597231B NO donor medicine and synthesis method thereof |
| 07/04/2012 | CN101591368B Girald pteroxygonum root neoflavonoid compound |
| 07/04/2012 | CN101589799B Multi-nutrient breakfast |
| 07/04/2012 | CN101588807B Use of d-ribose to treat cardiac arrhythmias |
| 07/04/2012 | CN101585859B Novel scutellarin derivative as well as preparation method and pharmaceutical composition thereof |
| 07/04/2012 | CN101583615B Spiropiperidine glycinamide derivatives |
| 07/04/2012 | CN101574392B Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid |
| 07/04/2012 | CN101564159B Food for reducing hypertension and diabetes and preparation method thereof |
| 07/04/2012 | CN101544610B Ligustrazine salt |
| 07/04/2012 | CN101439107B Chinese medicine granule containing haw thorn extract and preparation method thereof |
| 07/04/2012 | CN101439086B Chinese medicine granule containing total phenolic acids in salvia root and preparation method thereof |
| 07/04/2012 | CN101439082B Chinese medicine granule containing sophora root extract and preparation method thereof |
| 07/04/2012 | CN101416972B External medicine capable of preventing and treating cardiovascular disease and preparation method thereof |
| 07/04/2012 | CN101402565B Halogenated 2-(a-hydroxyl pentyl) benzoate, production method and uses thereof |
| 07/04/2012 | CN101381360B Grafts of plant polyphenol and weathered coal humic acid degradation product and grafting method |
| 07/04/2012 | CN101347255B Kudzu root drink and preparation method and equipment |
| 07/04/2012 | CN101347235B Cicer arietinum lipid-lowering nourishing powder and method of preparing the same |
| 07/04/2012 | CN101307044B Two crystallographic form of pinocembrin compounds, preparation method and applications for treating diseases |
| 07/04/2012 | CN101229254B Chinese traditional medicine preparation for treating cerebral apoplexy without sequelae |
| 07/04/2012 | CN101204535B Decoction medicine for retention of phlegmatic dampness hypertension |
| 07/04/2012 | CN101128197B Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion |
| 07/04/2012 | CN101106987B Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 07/04/2012 | CN101088522B Chinese medicine composition containing red sage, notoginseng and musk or muskone and its prepn |
| 07/04/2012 | CN101085064B Composition containing radix paeoniae rubrathe for treating cardiovascular diseases and its preparation |
| 07/03/2012 | US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 07/03/2012 | US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 07/03/2012 | US8212032 sEH inhibitors and their use |
| 07/03/2012 | US8211939 Isosorbide nitrates |
| 07/03/2012 | CA2661960C Noninvasive measurements of chemical substances |
| 07/03/2012 | CA2563264C Connexin 40 tissue specific gene mutations |
| 07/03/2012 | CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2 |
| 07/03/2012 | CA2521648C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 07/03/2012 | CA2481192C Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 07/03/2012 | CA2474894C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/03/2012 | CA2388818C C-aryl glucoside sglt2 inhibitors and method |
| 07/03/2012 | CA2370805C Ureas as cell adhesion modulators |
| 06/28/2012 | WO2012087180A1 Method for treating acute cerebral and spinal blood flow disorders of an ischaemic or haemorrhagic nature |
| 06/28/2012 | WO2012086727A1 Novel substituted isoquinoline derivative |
| 06/28/2012 | WO2012086184A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
| 06/28/2012 | WO2012085933A1 Pharmaceutical compositions of tenecteplase |
| 06/28/2012 | WO2012085683A1 The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents |
| 06/28/2012 | WO2012085230A1 Extract of the above-ground portions of gynandropsis gynandra or cleome gynandra, and cosmetic, dermatological or pharmaceutical compositions including same |
| 06/28/2012 | WO2012085226A1 Extract of aerial parts of maca rich in polyphenols and composition comprising same |
| 06/28/2012 | WO2012084999A1 Prokineticin 1 receptor agonists and their uses |
| 06/28/2012 | WO2012083548A1 Administration method of citicoline for treating stroke |
| 06/28/2012 | WO2012083436A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa |
| 06/28/2012 | WO2012061289A9 Methods for treatment of brain injury utilizing biologics |
| 06/28/2012 | WO2012047966A3 Compositions and methods for treating ocular edema, neovascularization and related diseases |
| 06/28/2012 | WO2012036412A9 Peptide having a vascularization-suppressing activity and a use therefor |
| 06/28/2012 | WO2012024519A4 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 06/28/2012 | WO2012008764A9 Composition for inducing multiple nuclear division of cells |
| 06/28/2012 | US20120165412 Use of Resveratrol or Another Hydroxylated Stilbene For Preserving Cognitive Functioning |
| 06/28/2012 | US20120165406 Bis-trifluoromethyl honokiol analogs and their use in treating cancers |
| 06/28/2012 | US20120165401 Aptamer for chymase, and use thereof |
| 06/28/2012 | US20120165398 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 06/28/2012 | US20120165392 Identification of Micro-RNAS Involved in Post-Myocardial Infarction Remodeling and Heart Failure |
| 06/28/2012 | US20120165391 Use of inhibitors of zdhhc2 activity for modulation of adipogenesis |
| 06/28/2012 | US20120165382 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 06/28/2012 | US20120165381 Dual-acting imidazole antihypertensive agents |
| 06/28/2012 | US20120165378 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 06/28/2012 | US20120165371 Spiro substituted compounds as angiogenesis inhibitors |
| 06/28/2012 | US20120165363 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders |
| 06/28/2012 | US20120165362 Androgen receptor modulator compounds and methods |
| 06/28/2012 | US20120165353 Novel phenylpyridine derivative and medicinal agent comprising same |
| 06/28/2012 | US20120165351 Quinazoline derivatives |
| 06/28/2012 | US20120165350 Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
| 06/28/2012 | US20120165348 Novel compounds |
| 06/28/2012 | US20120165337 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof |
| 06/28/2012 | US20120165333 C-met protein kinase inhibitors |
| 06/28/2012 | US20120165329 Compounds and methods for kinase modulation, and indications therefor |
| 06/28/2012 | US20120165327 Spiropiperidines for use as tryptase inhibitors |
| 06/28/2012 | US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors |
| 06/28/2012 | US20120165322 Rho kinase inhibitors |
| 06/28/2012 | US20120165321 Quinoline derivatives as pi3 kinase inhibitors |
| 06/28/2012 | US20120165311 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 06/28/2012 | US20120165307 Azaindoles useful as inhibitors of janus kinases |
| 06/28/2012 | US20120165306 Pyrazinylpyridines useful for the treatment of proliferative diseases |
| 06/28/2012 | US20120165303 Triazolyl phenyl benzenesulfonamides |
| 06/28/2012 | US20120165294 4,5-dihydro-oxazol-2yl derivatives |
| 06/28/2012 | US20120165293 Synthesis of prostanoids |
| 06/28/2012 | US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE |
| 06/28/2012 | US20120165285 Combined preparation for use as a medicament |
| 06/28/2012 | US20120165281 Stilbenoid derivatives and their uses |
| 06/28/2012 | US20120165280 Method for improving blood flow using stilbenoid derivatives |
| 06/28/2012 | US20120165251 Diabetes therapy |
| 06/28/2012 | US20120165245 Angiogenically effective unit dose of fgf and method of administering |
| 06/28/2012 | US20120164244 Combination of proanthocyanidins and centella asiatica for the treatment of atherosclerosis |
| 06/28/2012 | US20120164243 Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders |
| 06/28/2012 | US20120164226 Compositions and Methods for Improving Prognosis of a Human with Subarachnoid Hemorrhage |
| 06/28/2012 | US20120164221 Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night |
| 06/28/2012 | US20120164218 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 06/28/2012 | US20120164212 Stem cell beacon |
| 06/28/2012 | US20120164161 Antibodies and Uses Thereof |
| 06/28/2012 | US20120164157 Method of treating stroke with thrombolytic agent |
| 06/28/2012 | US20120164142 Compositions comprising natriuretic peptides and methods of use thereof |
| 06/28/2012 | US20120164120 Novel monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones |
| 06/28/2012 | US20120164117 Methods of generating human cardiac cells and tissues and uses thereof |